Discovering the Solid-State Secrets of Lorlatinib by NMR Crystallography: To Hydrogen Bond or not to Hydrogen Bond
Discovering the Solid-State Secrets of Lorlatinib by NMR Crystallography: To Hydrogen Bond or not to Hydrogen Bond
复制标题
通过 NMR 晶体学发现 Lorlatinib 的固态秘密:氢键或非氢键
DOI:
10.1016/j.xphs.2023.02.022
复制
发表时间:
2023
影响因子:
3.8
通讯作者:
Rehman Z
中科院分区:
文献类型:
--
作者:
Rehman Z
Lorlatinib is an active pharmaceutical ingredient (API) used in the treatment of lung cancer. Here, an NMR crystallography analysis is presented whereby the single-crystal X-ray diffraction structure (CSD: 2205098) determination is complemented by multinuclear (1H,13C,14/15N,19F) magic-angle spinning (MAS) solid-state NMR and gauge-including projector augmented wave (GIPAW) calculation of NMR chemical shifts. Lorlatinib crystallises in the P21space group, with two distinct molecules in the asymmetric unit cell,Z′ = 2. Three of the four NH2hydrogen atoms form intermolecular hydrogen bonds, N30-H…N15 between the two distinct molecules and N30-H…O2 between two equivalent molecules. This is reflected in one of the NH21H chemical shifts being significantly lower, 4.0 ppm compared to 7.0 ppm. Two-dimensional1H–13C,14N-1H and1H (double-quantum, DQ)-1H (single-quantum, SQ) MAS NMR spectra are presented. The1H resonances are assigned and specific Hsingle bondH proximities corresponding to the observed DQ peaks are identified. The resolution enhancement at a1H Larmor frequency of 1 GHz as compared to 500 or 600 MHz is demonstrated.